BEUDAMED
    FDA Adverse Event Injury Summary report: N

    ASR XL TAP SLV ADAP 12/14+2

    MDR report key: 2870436 · Received December 12, 2012

    Report

    Report Number
    1818910-2012-25819
    Event Type
    Injury
    Date Received
    December 12, 2012
    Date of Event
    January 25, 2007
    Report Date
    August 5, 2013
    Manufacturer
    DEPUY INTERNATIONAL
    Product Code
    KWA
    Removal / Correction Number
    Z-1749/1816-2011
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    US
    Reporter Occupation
    PATIENT

    Narratives

    Additional Manufacturer Narrative · 1

    DEPUY STILL CONSIDERS THE INVESTIGATION CLOSED.

    Additional Manufacturer Narrative · 1

    THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4).DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY.

    Additional Manufacturer Narrative · 1

    SINCE THE INFECTION OCCURRED 1.5+ YEARS AFTER IMPLANT, IT IS UNLIKELY THAT THE DEVICE CONTRIBUTED TO THE INFECTION. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME.

    Description of Event or Problem · 1

    ASR REVISION;LEFT ASR XL;REASON FOR REVISION: UNKNOWN.

    Description of Event or Problem · 1

    REASON(S) FOR REVISION: INFECTION (TESTED AND POSITIVE CULTURE CONFIRMED) 1.5+ YEARS AFTER IMPLANT.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1 ASR XL TAP SLV ADAP 12/14+2 ASR TOTAL HIP REPLACEMENT KWA DEPUY INTERNATIONAL 1876099

    Patients

    Seq Age Sex Outcome Treatment
    1 Required Intervention